BRZE Braze | $30.65
+3.1% | 6/6/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $51.00 -> $44.00 | High | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 6/6/2025 |
ZS Zscaler | $299.90
-1.0% | 6/6/2025 | Target Raised by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $290.00 -> $345.00 | Low | View details for Oppenheimer rating of Zscaler (NASDAQ:ZS) on 6/6/2025 |
SNOW Snowflake | $210.75
0.0% | 6/6/2025 | Target Raised by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $225.00 -> $250.00 | Low | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 6/6/2025 |
TRVI Trevi Therapeutics | $6.41
-9.2% | 6/2/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Medium | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 6/2/2025 |
CLYM Climb Bio | $1.34
-3.6% | 6/6/2025 | Initiated by | Oppenheimer | Analyst Leland Gershell | Outperform | $10.00 | High | View details for Oppenheimer rating of Climb Bio (NASDAQ:CLYM) on 6/6/2025 |
NET Cloudflare | $177.95
-1.0% | 6/5/2025 | Reiterated by | Oppenheimer | Analyst Param Singh | Outperform -> Outperform | $165.00 -> $200.00 | High | View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 6/5/2025 |
MCO Moody's | $485.72
-0.7% | 6/5/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $489.00 -> $523.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 6/5/2025 |
LVRO Lavoro | $2.52
-0.4% | 6/5/2025 | Reiterated by | Oppenheimer | Analyst Kristen Owen | Outperform -> Underperform | | Medium | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 6/5/2025 |
GWRE Guidewire Software | $257.35
+0.6% | 6/4/2025 | Target Raised by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $230.00 -> $275.00 | High | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 6/4/2025 |
CRWD CrowdStrike | $464.39
-0.9% | 6/4/2025 | Target Raised by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $410.00 -> $520.00 | High | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 6/4/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
FERG Ferguson | $213.86
+1.4% | 6/4/2025 | Target Raised by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $189.00 -> $235.00 | Medium | View details for Oppenheimer rating of Ferguson (NASDAQ:FERG) on 6/4/2025 |
CME CME Group | $268.35
-2.1% | 6/4/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $282.00 -> $300.00 | Low | View details for Oppenheimer rating of CME Group (NASDAQ:CME) on 6/4/2025 |
DG Dollar General | $113.32
-0.1% | 6/4/2025 | Upgraded by | Oppenheimer | Analyst Rupesh Parikh | Market Perform -> Outperform | $130.00 | Medium | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 6/4/2025 |
URGN UroGen Pharma | $7.02
-4.7% | 6/3/2025 | Target Lowered by | Oppenheimer | Analyst Leland Gershell | Outperform -> Outperform | $36.00 -> $10.00 | Low | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 6/3/2025 |
AXSM Axsome Therapeutics | $109.87
-1.8% | 6/3/2025 | Initiated by | Oppenheimer | Analyst Matthew Hershenhorn | Outperform | $185.00 | Low | View details for Oppenheimer rating of Axsome Therapeutics (NASDAQ:AXSM) on 6/3/2025 |
KALA KALA BIO | $4.11
-0.7% | 6/2/2025 | Reiterated by | Oppenheimer | Analyst Andreas Argyrides | Outperform | $15.00 | High | View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 6/2/2025 |
ABEO Abeona Therapeutics | $6.54
-3.0% | 6/2/2025 | Initiated by | Oppenheimer | Analyst Andreas Argyrides | Outperform | $19.00 | Low | View details for Oppenheimer rating of Abeona Therapeutics (NASDAQ:ABEO) on 6/2/2025 |
AQST Aquestive Therapeutics | $3.54
-0.6% | 6/2/2025 | Initiated by | Oppenheimer | Analyst Andreas Argyrides | Outperform | $7.00 | High | View details for Oppenheimer rating of Aquestive Therapeutics (NASDAQ:AQST) on 6/2/2025 |
DYN Dyne Therapeutics | $14.40
-2.0% | 6/2/2025 | Initiated by | Oppenheimer | Analyst Andreas Argyrides | Outperform | $60.00 -> $34.00 | High | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 6/2/2025 |
HRMY Harmony Biosciences | $35.42
-0.5% | 6/2/2025 | Initiated by | Oppenheimer | Analyst Andreas Argyrides | Outperform | $61.00 | High | View details for Oppenheimer rating of Harmony Biosciences (NASDAQ:HRMY) on 6/2/2025 |
MDWD MediWound | $21.46
-0.6% | 6/2/2025 | Initiated by | Oppenheimer | - | Outperform | $34.00 | Medium | View details for Oppenheimer rating of MediWound (NASDAQ:MDWD) on 6/2/2025 |
PRAX Praxis Precision Medicines | $44.51
-0.1% | 6/2/2025 | Target Set by | Oppenheimer | Analyst Jay Olson | Outperform | $97.00 | High | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 6/2/2025 |
TARS Tarsus Pharmaceuticals | $43.11
-1.8% | 6/2/2025 | Initiated by | Oppenheimer | - | Outperform | $75.00 | High | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 6/2/2025 |
WU Western Union | $9.28
-2.0% | 6/2/2025 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Western Union (NYSE:WU) on 6/2/2025 |
AII American Integrity Insurance Group | $17.05
+0.3% | 6/2/2025 | Initiated by | Oppenheimer | Analyst Michael Phillips | Market Perform | | Low | View details for Oppenheimer rating of American Integrity Insurance Group (NYSE:AII) on 6/2/2025 |
AVGO Broadcom | $244.28
-1.1% | 5/30/2025 | Target Raised by | Oppenheimer | Analyst Rick Schafer | Outperform -> Outperform | $225.00 -> $265.00 | High | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 5/30/2025 |
ZS Zscaler | $299.90
-1.0% | 5/30/2025 | Target Raised by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $250.00 -> $290.00 | Medium | View details for Oppenheimer rating of Zscaler (NASDAQ:ZS) on 5/30/2025 |
ULTA Ulta Beauty | $468.32
+0.6% | 5/30/2025 | Target Raised by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $465.00 -> $510.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 5/30/2025 |
NDSN Nordson | $219.28
+2.1% | 5/30/2025 | Upgraded by | Oppenheimer | Analyst Christopher Glynn | Market Perform -> Outperform | $260.00 | High | View details for Oppenheimer rating of Nordson (NASDAQ:NDSN) on 5/30/2025 |
ESTC Elastic | $85.82
-0.7% | 4/22/2025 | Target Lowered by | Oppenheimer | - | Outperform | $140.00 -> $120.00 | High | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 4/22/2025 |
IFRX InflaRx | $0.85
+2.4% | 5/29/2025 | Target Lowered by | Oppenheimer | Analyst Andreas Argyrides | Outperform -> Outperform | $6.00 -> $3.00 | Medium | View details for Oppenheimer rating of InflaRx (NASDAQ:IFRX) on 5/29/2025 |
YMAB Y-mAbs Therapeutics | $5.08
-3.6% | 5/29/2025 | Target Lowered by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $20.00 -> $15.00 | High | View details for Oppenheimer rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 5/29/2025 |
AI C3.ai | $25.86
-0.4% | 5/29/2025 | Target Lowered by | Oppenheimer | Analyst Timothy Horan | Outperform -> Outperform | $56.00 -> $45.00 | High | View details for Oppenheimer rating of C3.ai (NYSE:AI) on 5/29/2025 |
CRM Salesforce | $272.36
-0.8% | 5/29/2025 | Reiterated by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $380.00 -> $370.00 | High | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 5/29/2025 |
QSR Restaurant Brands International | $69.78
-2.1% | 5/27/2025 | Target Raised by | Oppenheimer | Analyst Brian Bittner | Outperform -> Outperform | $77.00 -> $80.00 | Low | View details for Oppenheimer rating of Restaurant Brands International (NYSE:QSR) on 5/27/2025 |
PRTA Prothena | $5.25
-3.0% | 5/27/2025 | Downgraded by | Oppenheimer | Analyst Jay Olson | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 5/27/2025 |
LAND Gladstone Land | $10.01
+2.2% | 5/23/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | High | View details for Oppenheimer rating of Gladstone Land (NASDAQ:LAND) on 5/23/2025 |
TVRD Cara Therapeutics | $26.90
-5.6% | 5/21/2025 | Initiated by | Oppenheimer | Analyst Jay Olson | Outperform | $65.00 | N/A | View details for Oppenheimer rating of Cara Therapeutics (NASDAQ:TVRD) on 5/21/2025 |
WDAY Workday | $252.90
+0.1% | 5/23/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $320.00 -> $300.00 | Medium | View details for Oppenheimer rating of Workday (NASDAQ:WDAY) on 5/23/2025 |
INTU Intuit | $764.38
-0.9% | 5/23/2025 | Reiterated by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $642.00 -> $742.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 5/23/2025 |
Why Elon put $51 million into this (Ad) Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists [See The Details Here] |
ADSK Autodesk | $297.21
-0.2% | 5/23/2025 | Reiterated by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $300.00 -> $350.00 | High | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 5/23/2025 |
BAC Bank of America | $44.93
-0.1% | 5/22/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 5/22/2025 |
EFX Equifax | $268.55
+0.1% | 5/22/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $277.00 -> $296.00 | High | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 5/22/2025 |
MOD Modine Manufacturing | $90.96
-2.8% | 5/22/2025 | Target Raised by | Oppenheimer | Analyst Noah Kaye | Outperform -> Outperform | $114.00 -> $121.00 | High | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 5/22/2025 |
SNOW Snowflake | $210.75
0.0% | 5/22/2025 | Reiterated by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $210.00 -> $225.00 | High | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 5/22/2025 |
TRU TransUnion | $87.37
+1.4% | 5/22/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $96.00 -> $100.00 | High | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 5/22/2025 |
C Citigroup | $78.17
-0.1% | 5/20/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | High | View details for Oppenheimer rating of Citigroup (NYSE:C) on 5/20/2025 |
ULTA Ulta Beauty | $468.32
+0.6% | 5/20/2025 | Reiterated by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $435.00 -> $465.00 | High | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 5/20/2025 |
LQDA Liquidia | $18.02
-0.7% | 5/19/2025 | Target Set by | Oppenheimer | Analyst Andreas Argyrides | Market Perform -> Underperform | $13.00 | High | View details for Oppenheimer rating of Liquidia (NASDAQ:LQDA) on 5/19/2025 |
ACAD ACADIA Pharmaceuticals | $22.30
+1.5% | 5/16/2025 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/16/2025 |
COIN Coinbase Global | $256.63
+2.1% | 5/15/2025 | Target Set by | Oppenheimer | Analyst Owen Lau | | $293.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 5/15/2025 |
CMMB Chemomab Therapeutics | $1.32
-0.1% | 5/16/2025 | Target Lowered by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $11.00 -> $10.00 | Medium | View details for Oppenheimer rating of Chemomab Therapeutics (NASDAQ:CMMB) on 5/16/2025 |
ADI Analog Devices | $227.66
+2.4% | 5/16/2025 | Target Raised by | Oppenheimer | Analyst Rick Schafer | Outperform -> Outperform | $225.00 -> $265.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 5/16/2025 |
WMS Advanced Drainage Systems | $116.79
+1.7% | 5/16/2025 | Target Lowered by | Oppenheimer | Analyst Bryan Blair | Outperform -> Outperform | $165.00 -> $160.00 | Low | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 5/16/2025 |
DE Deere & Company | $521.63
+0.3% | 5/16/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $513.00 -> $555.00 | Low | View details for Oppenheimer rating of Deere & Company (NYSE:DE) on 5/16/2025 |
RANI Rani Therapeutics | $0.57
+2.5% | 5/16/2025 | Target Lowered by | Oppenheimer | Analyst Andreas Argyrides | Outperform -> Outperform | $14.00 -> $4.00 | High | View details for Oppenheimer rating of Rani Therapeutics (NASDAQ:RANI) on 5/16/2025 |
CHTR Charter Communications | $394.56
-0.5% | 5/16/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $500.00 | Medium | View details for Oppenheimer rating of Charter Communications (NASDAQ:CHTR) on 5/16/2025 |
ACRV Acrivon Therapeutics | $1.28
-5.2% | 5/15/2025 | Target Lowered by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $10.00 -> $9.00 | High | View details for Oppenheimer rating of Acrivon Therapeutics (NASDAQ:ACRV) on 5/15/2025 |
TOL Toll Brothers | $109.57
+2.1% | 5/15/2025 | Target Lowered by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $165.00 -> $155.00 | Medium | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 5/15/2025 |
ALMS Alumis | $3.43
-4.5% | 5/15/2025 | Target Lowered by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $26.00 -> $25.00 | High | View details for Oppenheimer rating of Alumis (NASDAQ:ALMS) on 5/15/2025 |
JSPR Jasper Therapeutics | $5.94
-1.2% | 5/15/2025 | Target Lowered by | Oppenheimer | Analyst Jay Olson | Outperform -> Outperform | $80.00 -> $65.00 | Low | View details for Oppenheimer rating of Jasper Therapeutics (NASDAQ:JSPR) on 5/15/2025 |
AEVA Aeva Technologies | $21.78
+4.2% | 5/15/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $9.00 -> $18.00 | Medium | View details for Oppenheimer rating of Aeva Technologies (NASDAQ:AEVA) on 5/15/2025 |
WEX WEX | $138.91
+0.2% | 5/15/2025 | Initiated by | Oppenheimer | - | Market Perform | | Medium | View details for Oppenheimer rating of WEX (NYSE:WEX) on 5/15/2025 |
HLNE Hamilton Lane | $151.73
+0.6% | 5/15/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Medium | View details for Oppenheimer rating of Hamilton Lane (NASDAQ:HLNE) on 5/15/2025 |
ARES Ares Management | $172.36
-0.9% | 5/15/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Ares Management (NYSE:ARES) on 5/15/2025 |
LSEA Landsea Homes | $11.28
+0.2% | 5/13/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Landsea Homes (NASDAQ:LSEA) on 5/13/2025 |
MAIN Main Street Capital | $58.25
+1.3% | 5/13/2025 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | High | View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 5/13/2025 |
INO Inovio Pharmaceuticals | $2.22
-2.2% | 5/14/2025 | Target Lowered by | Oppenheimer | Analyst Jay Olson | Outperform -> Outperform | $15.00 -> $13.00 | Medium | View details for Oppenheimer rating of Inovio Pharmaceuticals (NASDAQ:INO) on 5/14/2025 |
UNH UnitedHealth Group | $303.08
0.0% | 5/14/2025 | Target Lowered by | Oppenheimer | Analyst Michael Wiederhorn | Outperform -> Outperform | $600.00 -> $400.00 | N/A | View details for Oppenheimer rating of UnitedHealth Group (NYSE:UNH) on 5/14/2025 |
YMAB Y-mAbs Therapeutics | $5.08
-3.6% | 5/14/2025 | Target Lowered by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $21.00 -> $20.00 | High | View details for Oppenheimer rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 5/14/2025 |
QUIK QuickLogic | $6.18
+8.8% | 5/14/2025 | Target Lowered by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $13.00 -> $11.00 | High | View details for Oppenheimer rating of QuickLogic (NASDAQ:QUIK) on 5/14/2025 |
DLR Digital Realty Trust | $176.69
-0.1% | 5/14/2025 | Initiated by | Oppenheimer | Analyst Timothy Horan | Outperform | $200.00 | Low | View details for Oppenheimer rating of Digital Realty Trust (NYSE:DLR) on 5/14/2025 |
OLMA Olema Pharmaceuticals | $4.38
-1.8% | 5/14/2025 | Target Lowered by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $25.00 -> $22.00 | Medium | View details for Oppenheimer rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 5/14/2025 |
ALLO Allogene Therapeutics | $1.41
-0.7% | 5/14/2025 | Target Lowered by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $10.00 -> $9.00 | High | View details for Oppenheimer rating of Allogene Therapeutics (NASDAQ:ALLO) on 5/14/2025 |
CORZ Core Scientific | $12.71
+4.3% | 5/14/2025 | Initiated by | Oppenheimer | Analyst Timothy Horan | Outperform | $15.00 | Medium | View details for Oppenheimer rating of Core Scientific (NASDAQ:CORZ) on 5/14/2025 |
PRQR ProQR Therapeutics | $1.83
-4.2% | 5/13/2025 | Target Lowered by | Oppenheimer | Analyst Andreas Argyrides | Outperform -> Outperform | $15.00 -> $9.00 | High | View details for Oppenheimer rating of ProQR Therapeutics (NASDAQ:PRQR) on 5/13/2025 |
KRRO Korro Bio | $14.85
+1.8% | 5/13/2025 | Target Lowered by | Oppenheimer | Analyst Andreas Argyrides | Outperform -> Outperform | $155.00 -> $90.00 | Low | View details for Oppenheimer rating of Korro Bio (NASDAQ:KRRO) on 5/13/2025 |
MOS Mosaic | $34.59
-0.6% | 5/13/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $33.00 -> $40.00 | Low | View details for Oppenheimer rating of Mosaic (NYSE:MOS) on 5/13/2025 |
NTR Nutrien | $60.48
+1.2% | 5/13/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $58.00 -> $63.00 | Low | View details for Oppenheimer rating of Nutrien (NYSE:NTR) on 5/13/2025 |
KD Kyndryl | $40.84
+1.2% | 5/13/2025 | Target Raised by | Oppenheimer | Analyst Ian Zaffino | Outperform -> Outperform | $43.00 -> $47.00 | Low | View details for Oppenheimer rating of Kyndryl (NYSE:KD) on 5/13/2025 |
PRSU Pursuit Attractions & Hospitality | $29.16
+2.6% | 5/13/2025 | Target Lowered by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $50.00 -> $41.00 | Low | View details for Oppenheimer rating of Pursuit Attractions & Hospitality (NYSE:PRSU) on 5/13/2025 |
MAIN Main Street Capital | $58.25
+1.3% | 5/13/2025 | Target Lowered by | Oppenheimer | Analyst Mitchel Penn | Market Perform -> Market Perform | $58.00 -> $53.00 | Low | View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 5/13/2025 |
FSK FS KKR Capital | $21.41
+0.5% | 5/9/2025 | Target Lowered by | Oppenheimer | Analyst Mitchel Penn | Market Perform -> Market Perform | $22.00 -> $21.00 | Low | View details for Oppenheimer rating of FS KKR Capital (NYSE:FSK) on 5/9/2025 |
GCMG GCM Grosvenor | $12.63
+1.0% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $16.00 -> $17.00 | Low | View details for Oppenheimer rating of GCM Grosvenor (NASDAQ:GCMG) on 5/9/2025 |
HUBS HubSpot | $606.92
-0.4% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $700.00 -> $750.00 | Low | View details for Oppenheimer rating of HubSpot (NYSE:HUBS) on 5/9/2025 |
PODD Insulet | $305.66
-2.0% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Steven Lichtman | Outperform -> Outperform | $312.00 -> $324.00 | Medium | View details for Oppenheimer rating of Insulet (NASDAQ:PODD) on 5/9/2025 |
LGND Ligand Pharmaceuticals | $109.48
+3.3% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Trevor Allred | Outperform -> Outperform | $142.00 -> $145.00 | Medium | View details for Oppenheimer rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 5/9/2025 |
LYFT Lyft | $15.63
+0.6% | 5/9/2025 | Reiterated by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $15.00 -> $17.00 | High | View details for Oppenheimer rating of Lyft (NASDAQ:LYFT) on 5/9/2025 |
ONTO Onto Innovation | $99.45
+3.5% | 5/9/2025 | Target Lowered by | Oppenheimer | Analyst Edward Yang | Outperform -> Outperform | $150.00 -> $130.00 | High | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 5/9/2025 |
SN SharkNinja | $87.89
+0.7% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $105.00 -> $120.00 | Low | View details for Oppenheimer rating of SharkNinja (NYSE:SN) on 5/9/2025 |
Trump’s Secret Weapon (Ad) The Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit
This isn't just a war of words. This is a financial time bomb.
The escalating battle between Donald Trump and Elon Musk isn't just political theater. It's a direct threat to the stability of markets, the dollar, and your life savings.
When two of the most powerful men in America go to war, the economy loses. Click here to get your FREE Presidential Transition Guide now |
SPT Sprout Social | $21.88
+0.7% | 5/9/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $38.00 -> $32.00 | High | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 5/9/2025 |
SG Sweetgreen | $14.00
-0.4% | 5/9/2025 | Target Lowered by | Oppenheimer | Analyst Brian Bittner | Outperform -> Outperform | $35.00 -> $29.00 | High | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 5/9/2025 |
TTD Trade Desk | $71.49
+0.0% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $75.00 -> $80.00 | Medium | View details for Oppenheimer rating of Trade Desk (NASDAQ:TTD) on 5/9/2025 |
TMDX TransMedics Group | $139.40
+0.3% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Suraj Kalia | Outperform -> Outperform | $125.00 -> $130.00 | High | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 5/9/2025 |
ARGX argenx | $583.62
-0.4% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Leland Gershell | Outperform -> Outperform | $704.00 -> $708.00 | Low | View details for Oppenheimer rating of argenx (NASDAQ:ARGX) on 5/9/2025 |
ZURA Zura Bio | $1.25
-0.8% | 5/9/2025 | Target Lowered by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $19.00 -> $17.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 5/9/2025 |
XERS Xeris Biopharma | $4.48
-2.2% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Leland Gershell | Outperform -> Outperform | $6.00 -> $7.00 | Medium | View details for Oppenheimer rating of Xeris Biopharma (NASDAQ:XERS) on 5/9/2025 |
BILL BILL | $45.62
| 5/9/2025 | Target Raised by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $50.00 -> $55.00 | Medium | View details for Oppenheimer rating of BILL (NYSE:BILL) on 5/9/2025 |
CEVA CEVA | $21.41
+5.8% | 5/9/2025 | Target Lowered by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $40.00 -> $33.00 | Low | View details for Oppenheimer rating of CEVA (NASDAQ:CEVA) on 5/9/2025 |
NET Cloudflare | $177.95
-1.0% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Param Singh | Outperform -> Outperform | $150.00 -> $165.00 | Medium | View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 5/9/2025 |
COIN Coinbase Global | $256.63
+2.1% | 5/9/2025 | Target Lowered by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $279.00 -> $269.00 | Medium | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 5/9/2025 |
COMP Compass | $6.17
-1.9% | 5/9/2025 | Reiterated by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $13.00 -> $12.00 | High | View details for Oppenheimer rating of Compass (NYSE:COMP) on 5/9/2025 |
CTVA Corteva | $72.00
+0.5% | 5/9/2025 | Reiterated by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $72.00 -> $75.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 5/9/2025 |
CRVS Corvus Pharmaceuticals | $4.04
+3.3% | 5/9/2025 | Reiterated by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $15.00 -> $17.00 | High | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 5/9/2025 |
EXPE Expedia Group | $176.62
+0.0% | 5/9/2025 | Target Lowered by | Oppenheimer | Analyst Jed Kelly | Outperform -> Outperform | $230.00 -> $210.00 | Medium | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 5/9/2025 |
PINS Pinterest | $34.17
-0.1% | 5/9/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $36.00 -> $40.00 | Low | View details for Oppenheimer rating of Pinterest (NYSE:PINS) on 5/9/2025 |
PSBD Palmer Square Capital BDC | $13.88
| 5/9/2025 | Downgraded by | Oppenheimer | Analyst Mitchel Penn | Outperform -> Market Perform | $17.00 -> $14.00 | High | View details for Oppenheimer rating of Palmer Square Capital BDC (NYSE:PSBD) on 5/9/2025 |
CNTA Centessa Pharmaceuticals | $11.94
+0.2% | 5/8/2025 | Initiated by | Oppenheimer | Analyst Andreas Argyrides | Outperform -> Outperform | $6.00 | Low | View details for Oppenheimer rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 5/8/2025 |
ASPN Aspen Aerogels | $6.19
+2.8% | 5/8/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Aspen Aerogels (NYSE:ASPN) on 5/8/2025 |
RVMD Revolution Medicines | $40.58
-1.2% | 5/8/2025 | Target Raised by | Oppenheimer | Analyst Jay Olson | Outperform -> Outperform | $70.00 -> $75.00 | Medium | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 5/8/2025 |
ROK Rockwell Automation | $324.14
-0.1% | 5/8/2025 | Target Raised by | Oppenheimer | Analyst Noah Kaye | Outperform -> Outperform | $258.00 -> $304.00 | Medium | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 5/8/2025 |
TPB Turning Point Brands | $74.73
-1.9% | 5/8/2025 | Target Raised by | Oppenheimer | Analyst Ian Zaffino | Outperform -> Outperform | $65.00 -> $85.00 | Medium | View details for Oppenheimer rating of Turning Point Brands (NYSE:TPB) on 5/8/2025 |
RLJ RLJ Lodging Trust | $7.40
-0.4% | 5/8/2025 | Target Lowered by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of RLJ Lodging Trust (NYSE:RLJ) on 5/8/2025 |
IFRX InflaRx | $0.85
+2.4% | 5/8/2025 | Initiated by | Oppenheimer | Analyst Andreas Argyrides | Outperform | $6.00 | High | View details for Oppenheimer rating of InflaRx (NASDAQ:IFRX) on 5/8/2025 |
APP AppLovin | $383.60
-8.2% | 5/8/2025 | Reiterated by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $560.00 -> $500.00 | Medium | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 5/8/2025 |
BSY Bentley Systems | $47.79
-3.9% | 5/8/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $49.00 -> $50.00 | Low | View details for Oppenheimer rating of Bentley Systems (NASDAQ:BSY) on 5/8/2025 |
CGBD Carlyle Secured Lending | $14.14
+0.9% | 5/8/2025 | Target Lowered by | Oppenheimer | Analyst Mitchel Penn | Market Perform -> Market Perform | $17.00 -> $15.00 | Medium | View details for Oppenheimer rating of Carlyle Secured Lending (NASDAQ:CGBD) on 5/8/2025 |
FICO Fair Isaac | $1,746.34
-1.6% | 5/8/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $2,116.00 -> $2,293.00 | Low | View details for Oppenheimer rating of Fair Isaac (NYSE:FICO) on 5/8/2025 |
IMCR Immunocore | $36.07
-3.2% | 5/8/2025 | Target Raised by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $85.00 -> $86.00 | High | View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 5/8/2025 |
JCI Johnson Controls International | $103.52
-0.3% | 5/8/2025 | Target Raised by | Oppenheimer | Analyst Noah Kaye | Outperform -> Outperform | $90.00 -> $96.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 5/8/2025 |
IMRX Immuneering | $2.17
+1.9% | 5/7/2025 | Target Lowered by | Oppenheimer | Analyst Jay Olson | Outperform -> Outperform | $25.00 -> $21.00 | High | View details for Oppenheimer rating of Immuneering (NASDAQ:IMRX) on 5/7/2025 |
CRBP Corbus Pharmaceuticals | $9.21
-0.2% | 5/7/2025 | Target Lowered by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $60.00 -> $56.00 | High | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/7/2025 |
SRPT Sarepta Therapeutics | $39.71
-7.7% | 5/7/2025 | Target Lowered by | Oppenheimer | Analyst Hartaj Singh | Outperform -> Outperform | $184.00 -> $123.00 | High | View details for Oppenheimer rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/7/2025 |
WMT Walmart | $97.45
0.0% | 5/7/2025 | Target Raised by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $100.00 -> $110.00 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 5/7/2025 |
PRCH Porch Group | $11.05
+1.7% | 5/7/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $8.00 -> $9.00 | High | View details for Oppenheimer rating of Porch Group (NASDAQ:PRCH) on 5/7/2025 |
EA Electronic Arts | $146.92
-1.8% | 5/7/2025 | Target Raised by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $170.00 -> $185.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 5/7/2025 |
DENN Denny's | $4.26
+5.7% | 5/6/2025 | Target Lowered by | Oppenheimer | Analyst Michael Tames | Outperform -> Outperform | $7.00 -> $6.00 | Medium | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 5/6/2025 |
ORIC ORIC Pharmaceuticals | $9.86
+5.8% | 5/6/2025 | Target Lowered by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $15.00 -> $12.00 | High | View details for Oppenheimer rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 5/6/2025 |
INVH Invitation Homes | $33.19
| 5/6/2025 | Target Raised by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $39.00 -> $41.00 | Low | View details for Oppenheimer rating of Invitation Homes (NYSE:INVH) on 5/6/2025 |
BIIB Biogen | $134.15
+0.8% | 5/2/2025 | Target Set by | Oppenheimer | Analyst Jay Olson | | $205.00 | High | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 5/2/2025 |
NOW ServiceNow | $1,027.05
-0.3% | 5/6/2025 | Reiterated by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $970.00 -> $1,100.00 | Low | View details for Oppenheimer rating of ServiceNow (NYSE:NOW) on 5/6/2025 |
CBOE Cboe Global Markets | $219.36
-1.5% | 5/5/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $237.00 -> $249.00 | N/A | View details for Oppenheimer rating of Cboe Global Markets (NASDAQ:CBOE) on 5/5/2025 |
OSIS OSI Systems | $227.78
+0.6% | 5/5/2025 | Target Raised by | Oppenheimer | Analyst Christopher Glynn | Outperform -> Outperform | $225.00 -> $260.00 | Low | View details for Oppenheimer rating of OSI Systems (NASDAQ:OSIS) on 5/5/2025 |
RBLX Roblox | $93.26
-2.7% | 5/5/2025 | Target Raised by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $70.00 -> $80.00 | Low | View details for Oppenheimer rating of Roblox (NYSE:RBLX) on 5/5/2025 |
WCC WESCO International | $176.62
+1.9% | 5/5/2025 | Target Lowered by | Oppenheimer | Analyst Christopher Glynn | Outperform -> Outperform | $225.00 -> $195.00 | Low | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 5/5/2025 |
IRDM Iridium Communications | $28.56
+2.9% | 5/5/2025 | Initiated by | Oppenheimer | Analyst Timothy Horan | Outperform | $34.00 | High | View details for Oppenheimer rating of Iridium Communications (NASDAQ:IRDM) on 5/5/2025 |
ASTS AST SpaceMobile | $34.82
+11.6% | 5/5/2025 | Initiated by | Oppenheimer | Analyst Timothy Horan | Market Perform | | High | View details for Oppenheimer rating of AST SpaceMobile (NASDAQ:ASTS) on 5/5/2025 |
AZO AutoZone | $3,692.96
-0.7% | 5/2/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $4,600.00 | Low | View details for Oppenheimer rating of AutoZone (NYSE:AZO) on 5/2/2025 |
CFLT Confluent | $24.39
+0.1% | 5/1/2025 | Target Lowered by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $35.00 -> $32.00 | High | View details for Oppenheimer rating of Confluent (NASDAQ:CFLT) on 5/1/2025 |
HUM Humana | $233.04
+1.0% | 5/1/2025 | Target Raised by | Oppenheimer | Analyst Michael Wiederhorn | Outperform -> Outperform | $300.00 -> $310.00 | Medium | View details for Oppenheimer rating of Humana (NYSE:HUM) on 5/1/2025 |
Get Ready for Elon Musk’s BIGGEST Comeback Yet (Ad) Tesla's About to Prove Everyone Wrong... Again
Back in 2018, when Jeff Brown told everyone to buy Tesla…
The "experts" said Elon was finished and Tesla was headed for bankruptcy.
Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. |
KLAC KLA | $829.29
+2.6% | 5/1/2025 | Target Raised by | Oppenheimer | Analyst Edward Yang | Outperform -> Outperform | $700.00 -> $740.00 | Low | View details for Oppenheimer rating of KLA (NASDAQ:KLAC) on 5/1/2025 |
LFUS Littelfuse | $222.69
+2.3% | 5/1/2025 | Target Lowered by | Oppenheimer | Analyst Christopher Glynn | Outperform -> Outperform | $310.00 -> $275.00 | Low | View details for Oppenheimer rating of Littelfuse (NASDAQ:LFUS) on 5/1/2025 |
SN SharkNinja | $87.89
+0.7% | 5/1/2025 | Target Lowered by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $130.00 -> $105.00 | Medium | View details for Oppenheimer rating of SharkNinja (NYSE:SN) on 5/1/2025 |
TKR Timken | $72.64
+1.2% | 5/1/2025 | Target Lowered by | Oppenheimer | Analyst Bryan Blair | Outperform -> Outperform | $90.00 -> $88.00 | Medium | View details for Oppenheimer rating of Timken (NYSE:TKR) on 5/1/2025 |
XPO XPO | $119.61
+1.0% | 5/1/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $142.00 -> $126.00 | Medium | View details for Oppenheimer rating of XPO (NYSE:XPO) on 5/1/2025 |
META Meta Platforms | $694.06
-0.5% | 5/1/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $650.00 -> $665.00 | High | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 5/1/2025 |
CAT Caterpillar | $358.12
+1.3% | 5/1/2025 | Upgraded by | Oppenheimer | Analyst Kristen Owen | Market Perform -> Outperform | $395.00 | Low | View details for Oppenheimer rating of Caterpillar (NYSE:CAT) on 5/1/2025 |
UPS United Parcel Service | $99.27
+1.0% | 4/30/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $126.00 -> $114.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 4/30/2025 |
GLW Corning | $50.93
+0.4% | 4/30/2025 | Target Lowered by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $58.00 -> $55.00 | Low | View details for Oppenheimer rating of Corning (NYSE:GLW) on 4/30/2025 |
CVLT Commvault Systems | $190.99
+1.3% | 4/30/2025 | Target Raised by | Oppenheimer | Analyst Param Singh | Outperform -> Outperform | $180.00 -> $200.00 | Low | View details for Oppenheimer rating of Commvault Systems (NASDAQ:CVLT) on 4/30/2025 |
SHOP Shopify | $107.80
-3.2% | 4/30/2025 | Target Lowered by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $150.00 -> $125.00 | High | View details for Oppenheimer rating of Shopify (NYSE:SHOP) on 4/30/2025 |
WIX Wix.com | $153.96
+1.1% | 4/30/2025 | Target Lowered by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $250.00 -> $220.00 | Medium | View details for Oppenheimer rating of Wix.com (NASDAQ:WIX) on 4/30/2025 |
FSLR First Solar | $160.16
-3.7% | 4/30/2025 | Downgraded by | Oppenheimer | Analyst Colin Rusch | Outperform -> Market Perform | | High | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 4/30/2025 |
BZH Beazer Homes USA | $22.01
+3.0% | 4/29/2025 | Reiterated by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $37.00 -> $33.00 | Low | View details for Oppenheimer rating of Beazer Homes USA (NYSE:BZH) on 4/29/2025 |
BAC Bank of America | $44.93
-0.1% | 4/28/2025 | Target Raised by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $50.00 -> $51.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/28/2025 |
CHD Church & Dwight | $98.67
-0.4% | 4/28/2025 | Target Lowered by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $120.00 -> $115.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 4/28/2025 |
C Citigroup | $78.17
-0.1% | 4/28/2025 | Target Raised by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $91.00 -> $94.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/28/2025 |
POOL Pool | $298.25
+0.4% | 4/28/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $370.00 -> $322.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 4/28/2025 |
USB U.S. Bancorp | $44.87
+0.2% | 4/28/2025 | Target Raised by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $57.00 -> $59.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 4/28/2025 |
AMZN Amazon.com | $216.98
+1.6% | 4/28/2025 | Target Lowered by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $260.00 -> $220.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 4/28/2025 |
CPAY Corpay | $342.86
+1.6% | 4/28/2025 | Initiated by | Oppenheimer | Analyst Rayna Kumar | Market Perform | | High | View details for Oppenheimer rating of Corpay (NYSE:CPAY) on 4/28/2025 |
ROP Roper Technologies | $573.08
+0.0% | 4/28/2025 | Reiterated by | Oppenheimer | Analyst Christopher Glynn | Outperform -> Outperform | $640.00 | High | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 4/28/2025 |
YUM Yum! Brands | $143.12
-1.2% | 4/28/2025 | Reiterated by | Oppenheimer | Analyst Brian Bittner | Outperform -> Outperform | $185.00 | Low | View details for Oppenheimer rating of Yum! Brands (NYSE:YUM) on 4/28/2025 |
PTC PTC | $170.19
-0.1% | 4/25/2025 | Target Lowered by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $210.00 -> $170.00 | Medium | View details for Oppenheimer rating of PTC (NASDAQ:PTC) on 4/25/2025 |
TRU TransUnion | $87.37
+1.4% | 4/25/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $93.00 -> $96.00 | Low | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 4/25/2025 |
CMCSA Comcast | $34.60
-0.3% | 4/25/2025 | Target Lowered by | Oppenheimer | Analyst Timothy Horan | Outperform -> Outperform | $55.00 -> $38.00 | Low | View details for Oppenheimer rating of Comcast (NASDAQ:CMCSA) on 4/25/2025 |
GILD Gilead Sciences | $113.00
+0.5% | 4/25/2025 | Target Lowered by | Oppenheimer | Analyst Hartaj Singh | Outperform -> Outperform | $132.00 -> $125.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 4/25/2025 |
GOOG Alphabet | $177.63
+1.5% | 4/25/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $185.00 -> $200.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 4/25/2025 |
EA Electronic Arts | $146.92
-1.8% | 4/25/2025 | Target Raised by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $140.00 -> $170.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 4/25/2025 |
GOOGL Alphabet | $176.09
+1.4% | 4/25/2025 | Target Raised by | Oppenheimer | - | Outperform | $185.00 -> $200.00 | High | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOGL) on 4/25/2025 |
MSCI MSCI | $557.80
-1.9% | 4/23/2025 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/23/2025 |
ENPH Enphase Energy | $43.26
+5.1% | 4/23/2025 | Target Set by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $84.00 | Medium | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 4/23/2025 |
ADSK Autodesk | $297.21
-0.2% | 4/24/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 4/24/2025 |
SEIC SEI Investments | $84.53
-1.3% | 4/24/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Medium | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 4/24/2025 |
LII Lennox International | $556.19
+0.7% | 4/24/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $600.00 | High | View details for Oppenheimer rating of Lennox International (NYSE:LII) on 4/24/2025 |
FIS Fidelity National Information Services | $81.71
+0.6% | 4/23/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $94.00 | Medium | View details for Oppenheimer rating of Fidelity National Information Services (NYSE:FIS) on 4/23/2025 |
DE Deere & Company | $521.63
+0.3% | 4/22/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $510.00 -> $513.00 | Low | View details for Oppenheimer rating of Deere & Company (NYSE:DE) on 4/22/2025 |
IFF International Flavors & Fragrances | $78.23
+1.7% | 4/22/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $104.00 -> $89.00 | Low | View details for Oppenheimer rating of International Flavors & Fragrances (NYSE:IFF) on 4/22/2025 |
INGR Ingredion | $138.26
+0.2% | 4/22/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $167.00 -> $155.00 | Low | View details for Oppenheimer rating of Ingredion (NYSE:INGR) on 4/22/2025 |
LVRO Lavoro | $2.52
-0.4% | 4/22/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $6.00 -> $5.00 | Low | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 4/22/2025 |
NTR Nutrien | $60.48
+1.2% | 4/22/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $60.00 -> $58.00 | Low | View details for Oppenheimer rating of Nutrien (NYSE:NTR) on 4/22/2025 |
AGCO AGCO | $103.20
+2.2% | 4/22/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $109.00 -> $106.00 | Medium | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 4/22/2025 |
BIOX Bioceres Crop Solutions | $4.86
-3.8% | 4/22/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Bioceres Crop Solutions (NASDAQ:BIOX) on 4/22/2025 |
CNH CNH GLOBAL N V Foreign | $12.86
+1.0% | 4/22/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $16.00 -> $15.00 | N/A | View details for Oppenheimer rating of CNH GLOBAL N V Foreign (NYSE:CNH) on 4/22/2025 |
LIEN Chicago Atlantic BDC | $9.75
-5.7% | 4/22/2025 | Initiated by | Oppenheimer | Analyst Mitchel Penn | Market Perform | | Low | View details for Oppenheimer rating of Chicago Atlantic BDC (NASDAQ:LIEN) on 4/22/2025 |
CF CF Industries | $92.84
+0.8% | 4/22/2025 | Downgraded by | Oppenheimer | Analyst Kristen Owen | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of CF Industries (NYSE:CF) on 4/22/2025 |
AEVA Aeva Technologies | $21.78
+4.2% | 4/21/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $6.00 -> $9.00 | Low | View details for Oppenheimer rating of Aeva Technologies (NASDAQ:AEVA) on 4/21/2025 |
UNH UnitedHealth Group | $303.08
0.0% | 4/21/2025 | Target Lowered by | Oppenheimer | Analyst Michael Wiederhorn | Outperform -> Outperform | $640.00 -> $600.00 | High | View details for Oppenheimer rating of UnitedHealth Group (NYSE:UNH) on 4/21/2025 |
NFLX Netflix | $1,224.46
-1.4% | 4/18/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1,150.00 -> $1,200.00 | N/A | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 4/18/2025 |
SUNS Sunrise Realty Trust | $10.98
+1.2% | 4/17/2025 | Initiated by | Oppenheimer | - | Outperform | $12.00 | High | View details for Oppenheimer rating of Sunrise Realty Trust (NASDAQ:SUNS) on 4/17/2025 |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
STEP StepStone Group | $58.04
0.0% | 4/16/2025 | Target Set by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $67.00 | Low | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 4/16/2025 |
OWL Blue Owl Capital | $19.20
-0.3% | 4/16/2025 | Target Set by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $24.00 | Low | View details for Oppenheimer rating of Blue Owl Capital (NYSE:OWL) on 4/16/2025 |
RDDT Reddit | $117.65
-3.0% | 4/16/2025 | Initiated by | Oppenheimer | - | Outperform | $125.00 | Low | View details for Oppenheimer rating of Reddit (NYSE:RDDT) on 4/16/2025 |
LYFT Lyft | $15.63
+0.6% | 4/16/2025 | Initiated by | Oppenheimer | - | Outperform | $15.00 | Medium | View details for Oppenheimer rating of Lyft (NASDAQ:LYFT) on 4/16/2025 |
ARES Ares Management | $172.36
-0.9% | 4/16/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $159.00 | Low | View details for Oppenheimer rating of Ares Management (NYSE:ARES) on 4/16/2025 |
CBOE Cboe Global Markets | $219.36
-1.5% | 4/11/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $233.00 -> $237.00 | N/A | View details for Oppenheimer rating of Cboe Global Markets (NASDAQ:CBOE) on 4/11/2025 |
CME CME Group | $268.35
-2.1% | 4/11/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $269.00 -> $279.00 | Low | View details for Oppenheimer rating of CME Group (NASDAQ:CME) on 4/11/2025 |
NDAQ Nasdaq | $85.65
+0.0% | 4/11/2025 | Target Lowered by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $89.00 -> $85.00 | Medium | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 4/11/2025 |
LOVE Lovesac | $20.25
+2.2% | 4/11/2025 | Reiterated by | Oppenheimer | Analyst Brian Nagel | Outperform -> Outperform | $35.00 -> $35.00 | Medium | View details for Oppenheimer rating of Lovesac (NASDAQ:LOVE) on 4/11/2025 |
INTU Intuit | $764.38
-0.9% | 4/11/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $722.00 -> $642.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 4/11/2025 |
ICHR Ichor | $18.62
+3.2% | 4/11/2025 | Target Lowered by | Oppenheimer | Analyst Edward Yang | Market Perform -> Market Perform | $35.00 -> $25.00 | Medium | View details for Oppenheimer rating of Ichor (NASDAQ:ICHR) on 4/11/2025 |
LRCX Lam Research | $88.30
+2.3% | 4/11/2025 | Target Lowered by | Oppenheimer | Analyst Ed Yang | Outperform -> Outperform | $95.00 -> $80.00 | Medium | View details for Oppenheimer rating of Lam Research (NASDAQ:LRCX) on 4/11/2025 |
UCTT Ultra Clean | $21.34
+3.0% | 4/11/2025 | Target Lowered by | Oppenheimer | Analyst Edward Yang | Outperform -> Outperform | $60.00 -> $30.00 | Medium | View details for Oppenheimer rating of Ultra Clean (NASDAQ:UCTT) on 4/11/2025 |
KLAC KLA | $829.29
+2.6% | 4/11/2025 | Target Lowered by | Oppenheimer | Analyst Edward Yang | Outperform -> Outperform | $850.00 -> $700.00 | Low | View details for Oppenheimer rating of KLA (NASDAQ:KLAC) on 4/11/2025 |
ONTO Onto Innovation | $99.45
+3.5% | 4/11/2025 | Target Lowered by | Oppenheimer | Analyst Edward Yang | Outperform -> Outperform | $240.00 -> $150.00 | Low | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 4/11/2025 |
BSY Bentley Systems | $47.79
-3.9% | 4/10/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $49.00 | Low | View details for Oppenheimer rating of Bentley Systems (NASDAQ:BSY) on 4/10/2025 |
RBLX Roblox | $93.26
-2.7% | 4/10/2025 | Upgraded by | Oppenheimer | Analyst Martin Yang | Market Perform -> Outperform | $70.00 -> $70.00 | Medium | View details for Oppenheimer rating of Roblox (NYSE:RBLX) on 4/10/2025 |
WMT Walmart | $97.45
0.0% | 4/7/2025 | Target Lowered by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $110.00 -> $95.00 | High | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 4/7/2025 |
AGYS Agilysys | $113.70
+0.7% | 4/9/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $135.00 -> $90.00 | High | View details for Oppenheimer rating of Agilysys (NASDAQ:AGYS) on 4/9/2025 |
SHAK Shake Shack | $124.71
-3.5% | 4/9/2025 | Target Lowered by | Oppenheimer | Analyst Brian Bittner | Outperform -> Outperform | $155.00 -> $125.00 | High | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 4/9/2025 |
FRSH Freshworks | $15.95
+1.7% | 4/9/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $24.00 -> $19.00 | High | View details for Oppenheimer rating of Freshworks (NASDAQ:FRSH) on 4/9/2025 |
ADSK Autodesk | $297.21
-0.2% | 4/8/2025 | Target Lowered by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $350.00 -> $300.00 | High | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 4/8/2025 |
XPO XPO | $119.61
+1.0% | 4/4/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $176.00 -> $142.00 | High | View details for Oppenheimer rating of XPO (NYSE:XPO) on 4/4/2025 |
RXO RXO | $16.21
+1.1% | 4/4/2025 | Downgraded by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of RXO (NYSE:RXO) on 4/4/2025 |
T AT&T | $27.88
-0.7% | 4/1/2025 | Target Raised by | Oppenheimer | Analyst Timothy Horan | Outperform -> Outperform | $27.00 -> $32.00 | Low | View details for Oppenheimer rating of AT&T (NYSE:T) on 4/1/2025 |
VZ Verizon Communications | $43.66
-0.3% | 4/1/2025 | Target Raised by | Oppenheimer | Analyst Timothy Horan | Outperform -> Outperform | $48.00 -> $50.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/1/2025 |
APP AppLovin | $383.60
-8.2% | 3/27/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $560.00 | High | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 3/27/2025 |
OUST Ouster | $15.19
+4.1% | 3/27/2025 | Initiated by | Oppenheimer | Analyst Colin Rusch | Outperform | $16.00 | High | View details for Oppenheimer rating of Ouster (NYSE:OUST) on 3/27/2025 |
AUR Aurora Innovation | $5.88
+0.2% | 3/27/2025 | Initiated by | Oppenheimer | Analyst Colin Rusch | Outperform | $15.00 | High | View details for Oppenheimer rating of Aurora Innovation (NASDAQ:AUR) on 3/27/2025 |
BMEA Biomea Fusion | $2.63
+5.6% | 3/24/2025 | Target Set by | Oppenheimer | - | | $10.00 | Low | View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 3/24/2025 |
CRVS Corvus Pharmaceuticals | $4.04
+3.3% | 3/26/2025 | Reiterated by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $14.00 -> $15.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/26/2025 |
ZURA Zura Bio | $1.25
-0.8% | 3/26/2025 | Reiterated by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $20.00 -> $19.00 | Medium | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 3/26/2025 |
OPT Opthea | $3.41
+7.2% | 3/24/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | N/A | View details for Oppenheimer rating of Opthea (NASDAQ:OPT) on 3/24/2025 |
QNCX Quince Therapeutics | $1.17
| 3/24/2025 | Initiated by | Oppenheimer | Analyst Leland Gershell | Outperform | $10.00 | High | View details for Oppenheimer rating of Quince Therapeutics (NASDAQ:QNCX) on 3/24/2025 |
FDX FedEx | $222.12
+1.1% | 3/21/2025 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/21/2025 |
ASO Academy Sports and Outdoors | $44.37
+2.1% | 3/21/2025 | Target Lowered by | Oppenheimer | Analyst Brian Nagel | Outperform -> Outperform | $85.00 -> $70.00 | Medium | View details for Oppenheimer rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/21/2025 |
AMPX Amprius Technologies | $3.15
+8.6% | 3/21/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $14.00 -> $15.00 | High | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/21/2025 |
MPWR Monolithic Power Systems | $706.28
+2.8% | 3/21/2025 | Reiterated by | Oppenheimer | Analyst Rick Schafer | Outperform -> Outperform | $800.00 -> $800.00 | High | View details for Oppenheimer rating of Monolithic Power Systems (NASDAQ:MPWR) on 3/21/2025 |
VOR Vor Biopharma | $0.22
-0.4% | 3/21/2025 | Reiterated by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $8.00 -> $8.00 | High | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2025 |
DRI Darden Restaurants | $219.75
+1.0% | 3/21/2025 | Target Raised by | Oppenheimer | Analyst Brian Bittner | Outperform -> Outperform | $218.00 -> $230.00 | Medium | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/21/2025 |
FSLY Fastly | $8.29
+8.2% | 3/20/2025 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Fastly (NYSE:FSLY) on 3/20/2025 |
NET Cloudflare | $177.95
-1.0% | 3/20/2025 | Initiated by | Oppenheimer | - | Outperform | $150.00 | Low | View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 3/20/2025 |
LRCX Lam Research | $88.30
+2.3% | 3/20/2025 | Initiated by | Oppenheimer | - | Outperform | $95.00 | Low | View details for Oppenheimer rating of Lam Research (NASDAQ:LRCX) on 3/20/2025 |
AKAM Akamai Technologies | $78.08
+1.4% | 3/20/2025 | Initiated by | Oppenheimer | Analyst Param Singh | Outperform | $116.00 -> $100.00 | Low | View details for Oppenheimer rating of Akamai Technologies (NASDAQ:AKAM) on 3/20/2025 |
AEVA Aeva Technologies | $21.78
+4.2% | 3/20/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $5.00 -> $6.00 | High | View details for Oppenheimer rating of Aeva Technologies (NASDAQ:AEVA) on 3/20/2025 |
MOS Mosaic | $34.59
-0.6% | 3/20/2025 | Upgraded by | Oppenheimer | Analyst Kristen Owen | Market Perform -> Outperform | $33.00 -> $33.00 | Medium | View details for Oppenheimer rating of Mosaic (NYSE:MOS) on 3/20/2025 |
CDNS Cadence Design Systems | $301.66
+1.6% | 3/19/2025 | Target Lowered by | Oppenheimer | Analyst Edward Yang | Underperform -> Underperform | $225.00 -> $200.00 | Medium | View details for Oppenheimer rating of Cadence Design Systems (NASDAQ:CDNS) on 3/19/2025 |
OLMA Olema Pharmaceuticals | $4.38
-1.8% | 3/19/2025 | Reiterated by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $30.00 -> $25.00 | High | View details for Oppenheimer rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/19/2025 |
JEF Jefferies Financial Group | $53.45
+2.0% | 3/19/2025 | Downgraded by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 3/19/2025 |
GS The Goldman Sachs Group | $613.29
-0.1% | 3/19/2025 | Downgraded by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Market Perform | | Medium | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 3/19/2025 |
CG The Carlyle Group | $46.58
+0.6% | 3/19/2025 | Downgraded by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Market Perform | | High | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 3/19/2025 |
TSLA Tesla | $308.58
+4.6% | 3/18/2025 | Reiterated by | Oppenheimer | - | Mixed -> Mixed | | Medium | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/18/2025 |
EXPE Expedia Group | $176.62
+0.0% | 3/17/2025 | Target Lowered by | Oppenheimer | Analyst Jed Kelly | Outperform -> Outperform | $235.00 -> $230.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 3/17/2025 |
PHAR Pharming Group | $11.81
-0.4% | 3/14/2025 | Target Raised by | Oppenheimer | Analyst Michael Carrier | Outperform -> Outperform | $30.00 -> $39.00 | Low | View details for Oppenheimer rating of Pharming Group (NASDAQ:PHAR) on 3/14/2025 |
EVCM EverCommerce | $10.30
+0.4% | 3/14/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $13.00 -> $12.00 | High | View details for Oppenheimer rating of EverCommerce (NASDAQ:EVCM) on 3/14/2025 |
NKTR Nektar Therapeutics | $8.79
-12.0% | 3/14/2025 | Upgraded by | Oppenheimer | Analyst Jay Olson | Market Perform -> Outperform | $6.00 | High | View details for Oppenheimer rating of Nektar Therapeutics (NASDAQ:NKTR) on 3/14/2025 |
ADBE Adobe | $416.26
-0.2% | 3/13/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $560.00 -> $530.00 | High | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/13/2025 |
FERG Ferguson | $213.86
+1.4% | 3/12/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $234.00 -> $189.00 | Low | View details for Oppenheimer rating of Ferguson (NASDAQ:FERG) on 3/12/2025 |
ARVN Arvinas | $7.83
+4.0% | 3/11/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Medium | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 3/11/2025 |
TRVI Trevi Therapeutics | $6.41
-9.2% | 3/11/2025 | Target Raised by | Oppenheimer | Analyst Leland Gershell | Outperform -> Outperform | $12.00 -> $20.00 | High | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/11/2025 |
